By combining immunohistochemical analysis and transgenic mouse techniques we were able to show that shortly after acute brain injuries a subset of microglia indeed activated the NG2 locus leading to either EYFP expression or tdT recombination. The gene discussed is CSPG4; the disease is brain injury.